Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Shares

No definition available.

Name:	endp_AssetAcquisitionEquityInterestIssuedOrIssuableNumberOfShares
Namespace Prefix:	endp_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Share Price

+ References

No definition available.

+ Details

Name:	endp_AssetAcquisitionSharePrice
Namespace Prefix:	endp_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

License Agreement, Royalty Rate, Percentage of Net Sales

+ References

No definition available.

+ Details

Name:	endp_LicenseAgreementRoyaltyRatePercentageOfNetSales
Namespace Prefix:	endp_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of In Process Research And Development Projects Acquired

+ References

No definition available.

+ Details

Name:	endp_NumberOfInProcessResearchAndDevelopmentProjectsAcquired
Namespace Prefix:	endp_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Payments Of Additional Achievement Certain Commercial Milestones

+ References

No definition available.

+ Details

Name:	endp_PaymentsOfAdditionalAchievementCertainCommercialMilestones
Namespace Prefix:	endp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payments Of Additional Achievement Certain Development And Regulatory Milestones

+ References

No definition available.

+ Details

Name:	endp_PaymentsOfAdditionalAchievementCertainDevelopmentAndRegulatoryMilestones
Namespace Prefix:	endp_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow associated with the purchase of noncontrolling interest during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.

+ References

+ Details

Name:	us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(1)(a))
-URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910

+ Details

Name:	us-gaap_RestrictedCash
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	srt_CounterpartyNameAxis=endp_NevakarInjectablesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=endp_TLCAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AssetAcquisitionAxis=endp_BioSpecificsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=endp_XIAFLEXAndQWOMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

LICENSE, COLLABORATION AND ASSET ACQUISITION AGREEMENTS - Narrative (Details) $ / shares in Units, $ in Millions		1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 01, 2020 shares	May 31, 2022 USD ($) project	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Oct. 19, 2020 $ / shares
Nevakar Injectables, Inc
Collaborative Arrangement and Arrangement Other than Collaborative
Number of in process research and development projects acquired \| project		6
Acquired in-process research and development		$ 35.0
TLC Agreement
Collaborative Arrangement and Arrangement Other than Collaborative
Acquired in-process research and development			$ 30.0
Investment in subsidiary			110.0
Payments of additional achievement certain development and regulatory milestones			30.0
Payments of additional achievement certain commercial milestones			$ 500.0
Cash into bank account				$ 85.0
Minimum
Collaborative Arrangement and Arrangement Other than Collaborative
Royalty rate on net sales	5.00%
Maximum
Collaborative Arrangement and Arrangement Other than Collaborative
Royalty rate on net sales	15.00%
BioSpecifics
Collaborative Arrangement and Arrangement Other than Collaborative
Price per share of BioSpecifics Technologies Corp acquired (in dollars per shares) \| $ / shares					$ 88.50
Number of shares issued as a part of asset acquisition (in shares) \| shares	6,159,975
BioSpecifics \| XIAFLEX and QWO
Collaborative Arrangement and Arrangement Other than Collaborative
Intangible life (years)				13 years 7 months 6 days